-
公开(公告)号：US12053439B2
公开(公告)日：2024-08-06
申请号：US17198102
申请日：2021-03-10
IPC分类号： A61K31/12 , A61K8/35 , A61K8/9789 , A61K8/9794 , A61K36/23 , A61Q17/04
CPC分类号： A61K31/12 , A61K8/35 , A61K8/9789 , A61K8/9794 , A61K36/23 , A61Q17/04 , A61K31/12 , A61K2300/00
摘要： Methods of making safe extracts of Curcuma are provided. The processes provided include methods that use an extraction solvent that is at least substantially non-toxic and useful also as a pharmaceutically acceptable carrier in liquid dosage forms. The processes can produce a significantly higher yield from a single extraction than the state-of-the-art processes. For example, liquid dosage forms can be produced directly from the extraction process without requiring removal of the extraction solvent, reducing complexity and cost of processing over the state-of-the-art. Methods of making microemulsions and nanoemulsions are also provided to enhance the bioavailability and stability of the extracts.
-
公开(公告)号：US10973778B2
公开(公告)日：2021-04-13
申请号：US16264301
申请日：2019-01-31
IPC分类号： A61K31/12 , A61K8/35 , A61Q17/04 , A61K36/23 , A61K8/9789 , A61K8/9794
摘要： Methods of making safe extracts of Curcuma longa L. are provided. The processes provided include methods that use an extraction solvent that is at least substantially non-toxic and useful also as a pharmaceutically acceptable carrier in liquid dosage forms. The processes can produce a significantly higher yield from a single extraction than the state-of-the-art processes. For example, liquid dosage forms can be produced directly from the extraction process without requiring removal of the extraction solvent, reducing complexity and cost of processing over the state-of-the-art. Methods of making microemulsions and nanoemulsions are also provided to enhance the bioavailability and stability of the extracts.
-
公开(公告)号：US20240342112A1
公开(公告)日：2024-10-17
申请号：US18752500
申请日：2024-06-24
IPC分类号： A61K31/12 , A61K8/35 , A61K8/9789 , A61K8/9794 , A61K36/23 , A61Q17/04
CPC分类号： A61K31/12 , A61K8/35 , A61K8/9789 , A61K8/9794 , A61K36/23 , A61Q17/04
摘要： Methods of treating various types of tissue with safe extracts of Curcuma are provided. The processes provided include methods of making and using an extraction solvent that is at least substantially non-toxic and useful also as a pharmaceutically acceptable carrier in liquid dosage forms. The processes can produce a significantly higher yield from a single extraction than the state-of-the-art processes. For example, liquid dosage forms can be produced directly from the extraction process without requiring removal of the extraction solvent, reducing complexity and cost of processing over the state-of-the-art. Methods of making microemulsions and nanoemulsions are also provided to enhance the bioavailability and stability of the extracts.
-
公开(公告)号：US20210267913A1
公开(公告)日：2021-09-02
申请号：US17198102
申请日：2021-03-10
IPC分类号： A61K31/12 , A61K8/35 , A61Q17/04 , A61K36/23 , A61K8/9789 , A61K8/9794
摘要： Methods of making safe extracts of Curcuma are provided. The processes provided include methods that use an extraction solvent that is at least substantially non-toxic and useful also as a pharmaceutically acceptable carrier in liquid dosage forms. The processes can produce a significantly higher yield from a single extraction than the state-of-the-art processes. For example, liquid dosage forms can be produced directly from the extraction process without requiring removal of the extraction solvent, reducing complexity and cost of processing over the state-of-the-art. Methods of making microemulsions and nanoemulsions are also provided to enhance the bioavailability and stability of the extracts.
-
公开(公告)号：US20190160024A1
公开(公告)日：2019-05-30
申请号：US16264301
申请日：2019-01-31
摘要： Methods of making safe extracts of Curcuma longa L. are provided. The processes provided include methods that use an extraction solvent that is at least substantially non-toxic and useful also as a pharmaceutically acceptable carrier in liquid dosage forms. The processes can produce a significantly higher yield from a single extraction than the state-of-the-art processes. For example, liquid dosage forms can be produced directly from the extraction process without requiring removal of the extraction solvent, reducing complexity and cost of processing over the state-of-the-art. Methods of making microemulsions and nanoemulsions are also provided to enhance the bioavailability and stability of the extracts.
-
-
-
-
搜索结果
5 条记录 (耗时 0.019 秒)
